Jiumao Lin

1.8k total citations
87 papers, 1.5k citations indexed

About

Jiumao Lin is a scholar working on Molecular Biology, Oncology and Cancer Research. According to data from OpenAlex, Jiumao Lin has authored 87 papers receiving a total of 1.5k indexed citations (citations by other indexed papers that have themselves been cited), including 42 papers in Molecular Biology, 23 papers in Oncology and 17 papers in Cancer Research. Recurrent topics in Jiumao Lin's work include Traditional Chinese Medicine Analysis (9 papers), Pharmacological Effects of Natural Compounds (8 papers) and Urinary Bladder and Prostate Research (8 papers). Jiumao Lin is often cited by papers focused on Traditional Chinese Medicine Analysis (9 papers), Pharmacological Effects of Natural Compounds (8 papers) and Urinary Bladder and Prostate Research (8 papers). Jiumao Lin collaborates with scholars based in China, United States and India. Jiumao Lin's co-authors include Jun Peng, Jun Peng, Youqin Chen, Lihui Wei, Zhenfeng Hong, Lidian Chen, Jing Tao, Jinyan Zhao, Shan Lin and Wei Xu and has published in prestigious journals such as SHILAP Revista de lepidopterología, Cancer Research and Scientific Reports.

In The Last Decade

Jiumao Lin

83 papers receiving 1.5k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Jiumao Lin China 22 703 284 247 214 189 87 1.5k
Liuting Zeng China 25 714 1.0× 211 0.7× 102 0.4× 192 0.9× 204 1.1× 73 1.8k
Li Wu China 31 1.1k 1.6× 164 0.6× 222 0.9× 297 1.4× 145 0.8× 84 2.4k
Nu‐Man Tsai Taiwan 22 671 1.0× 150 0.5× 156 0.6× 130 0.6× 116 0.6× 76 1.5k
Hui Cai China 26 954 1.4× 113 0.4× 181 0.7× 270 1.3× 119 0.6× 78 1.8k
Piao Luo China 21 654 0.9× 204 0.7× 114 0.5× 180 0.8× 91 0.5× 54 1.4k
Haibo Cheng China 21 506 0.7× 174 0.6× 114 0.5× 107 0.5× 123 0.7× 79 1.1k
Ting Zhao China 26 865 1.2× 92 0.3× 239 1.0× 231 1.1× 86 0.5× 141 2.2k
Baolin Liu China 22 556 0.8× 139 0.5× 118 0.5× 119 0.6× 186 1.0× 53 1.3k
Weifan Yao China 26 1.2k 1.7× 107 0.4× 348 1.4× 457 2.1× 146 0.8× 53 2.0k

Countries citing papers authored by Jiumao Lin

Since Specialization
Citations

This map shows the geographic impact of Jiumao Lin's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Jiumao Lin with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Jiumao Lin more than expected).

Fields of papers citing papers by Jiumao Lin

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Jiumao Lin. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Jiumao Lin. The network helps show where Jiumao Lin may publish in the future.

Co-authorship network of co-authors of Jiumao Lin

This figure shows the co-authorship network connecting the top 25 collaborators of Jiumao Lin. A scholar is included among the top collaborators of Jiumao Lin based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Jiumao Lin. Jiumao Lin is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
2.
3.
Lu, Yao, Honglin An, Jinhong Liu, et al.. (2023). MicroRNA-204-5p Inhibits Hepatocellular Carcinoma by Targeting the Regulator of G Protein Signaling 20. ACS Pharmacology & Translational Science. 6(12). 1817–1828. 6 indexed citations
4.
Huang, Bin, Honglin An, Jiayu Shen, et al.. (2023). Babao Dan alleviates gut immune and microbiota disorders while impacting the TLR4/MyD88/NF-кB pathway to attenuate 5-Fluorouracil-induced intestinal injury. Biomedicine & Pharmacotherapy. 166. 115387–115387. 44 indexed citations
5.
Mao, Qianqian, Juan Min, Haiqin Liu, et al.. (2022). Self-assembled traditional Chinese nanomedicine modulating tumor immunosuppressive microenvironment for colorectal cancer immunotherapy. Theranostics. 12(14). 6088–6105. 72 indexed citations
6.
Cao, Zhiyun, Bin Guan, Lihui Wei, et al.. (2021). Effect of Babao Dan on angiogenesis of gastric cancer in vitro by regulating VEGFA/VEGFR2 signaling pathway. Translational Cancer Research. 10(2). 953–965. 8 indexed citations
7.
Huang, Bin, et al.. (2021). Qingjie Fuzheng Granule suppresses lymphangiogenesis in colorectal cancer via the VEGF-C/VEGFR-3 dependent PI3K/AKT pathway. Biomedicine & Pharmacotherapy. 137. 111331–111331. 21 indexed citations
8.
Yang, Hong, et al.. (2020). Down-regulated Solute Carrier Family 4 Member 4 Predicts Poor Progression in Colorectal Cancer. Journal of Cancer. 11(12). 3675–3684. 14 indexed citations
9.
Zheng, Liangpu, et al.. (2020). Establishment of a stable hepatic metastasis mouse model of murine colorectal cancer by microsurgical orthotopic implantation. Translational Cancer Research. 9(5). 3249–3257. 5 indexed citations
10.
Shen, Aling, Youqin Chen, Liya Liu, et al.. (2019). EBF1-Mediated Upregulation of Ribosome Assembly Factor PNO1 Contributes to Cancer Progression by Negatively Regulating the p53 Signaling Pathway. Cancer Research. 79(9). 2257–2270. 56 indexed citations
11.
Cao, Zhiyun, Jinyan Zhao, Jun Peng, et al.. (2019). Babao Dan induces gastric cancer cell apoptosis via regulating MAPK and NF-κB signaling pathways. Journal of International Medical Research. 47(10). 5106–5119. 18 indexed citations
12.
Lin, Jiumao, et al.. (2015). Qianliening capsules influence the apoptosis of benign prostatic hyperplasia epithelial-1 cells by regulating the extracellular matrix. Molecular Medicine Reports. 11(5). 3734–3740. 3 indexed citations
13.
Lin, Jiumao, et al.. (2014). Qianliening capsule inhibits benign prostatic hyperplasia angiogenesis via the HIF-1α signaling pathway. Experimental and Therapeutic Medicine. 8(1). 118–124. 10 indexed citations
14.
15.
Huang, Yuan, et al.. (2013). Clinical research in individual information of celiac artery CT imaging and gastric cancer surgery. Clinical & Translational Oncology. 15(10). 774–779. 12 indexed citations
16.
Feng, Xiaodong, Shanli Yang, Jiao Liu, et al.. (2013). Electroacupuncture ameliorates cognitive impairment through inhibition of NF-κB-mediated neuronal cell apoptosis in cerebral ischemia-reperfusion injured rats. Molecular Medicine Reports. 7(5). 1516–1522. 94 indexed citations
17.
Zheng, Haiyin, Wei Xu, Jiumao Lin, Jun Peng, & Zhenfeng Hong. (2013). Qianliening capsule treats benign prostatic hyperplasia via induction of prostatic cell apoptosis. Molecular Medicine Reports. 7(3). 848–854. 19 indexed citations
18.
Hu, Haixia, Zuanfang Li, Xiaoqin Zhu, et al.. (2013). Gua Lou Gui Zhi decoction suppresses LPS-induced activation of the TLR4/NF-κB pathway in BV-2 murine microglial cells. International Journal of Molecular Medicine. 31(6). 1327–1332. 20 indexed citations
19.
Liu, Xianxiang, et al.. (2012). Molecular mechanism of Tougu Xiaotong capsules for subchondral bone remodeling in knee osteoarthritis. Zhongguo zuzhi gongcheng yanjiu yu linchuang kangfu. 16(15). 2669. 1 indexed citations
20.
Lin, Jiumao, Lihui Wei, Wei Xu, et al.. (2012). Hedyotis diffusa Willd extract inhibits HT-29 cell proliferation via cell cycle arrest. Experimental and Therapeutic Medicine. 4(2). 307–310. 30 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Liuting Zeng Breakdown of academic impact, for papers by Li Wu Breakdown of academic impact, for papers by Nu‐Man Tsai Breakdown of academic impact, for papers by Hui Cai Breakdown of academic impact, for papers by Piao Luo Breakdown of academic impact, for papers by Haibo Cheng Breakdown of academic impact, for papers by Ting Zhao Breakdown of academic impact, for papers by Baolin Liu Breakdown of academic impact, for papers by Weifan Yao
Rankless by CCL
2026